“The microbial biomass that exists on us functions like another organ. Clearly the human microbiome is necessary for human health, but the scientific community has only just begun to understand its importance. Our human genome consists of 23,000 genes. In contrast, the microbiome genome collectively consists of millions of functioning genes. Whereas traditional gene therapy is viewed as difficult, costly and dangerous, this colossal microbial genome far more readily lends itself to genetic manipulation. We now have the potential to make gene therapy commonplace.”
Nicholas T. Monsul, M.D., President & CEO
Biofilm Solutions and Comparative Testing Services for Researchers, Medical Professionals and Formulation Scientists
From implants and medical devices, to manufacturing systems, to human infections, understanding bacterial growth characteristics has become the ultimate weapon in solving today’s contamination and infection issues. Simple, earlier tests and standards involving antimicrobials and disinfectants against planktonic, or free-floating bacteria are now known to be less relevant than testing “true-life” scenarios. Biofilms are nearly ubiquitous bacterial colonizations that once adhered and formed can exhibit antimicrobial resistance beyond 1000-fold over simple planktonic bacteria.
Quorum Biofilm Research Laboratories scientists are dedicated to developing solutions for these real-world problems. We are able to stringently test antimicrobial formulations against an array of common biofilms in standard models, as well as custom models for researchers in many fields. Let our team of experts help solve your biofilm issues.
